GLP1R and cholelithiasis: Clinical data show that gastrointestinal side effects are the most common and frequent adverse reactions following the use of GLP-1R agonist analogs, manifesting as nausea, vomiting, diarrhea, and possibly cholelithiasis, which generally appear to be dose-related and transient, disappearing with continuation of therapy (Fineman et al., 2004).